This research focuses on the modeling of dendrimer molecules for their application as delivery vectors within drug and gene therapy systems. We examine how the architecture and composition of dendrimers affect their drug and gene binding efficacies along with their interactions with anionic bilayers. We specifically focus on how the weakly basic nature of dendrimer monomers and the addition of neutral grafts to dendrimer surface groups affect their interactions with drugs, linear polyelectrolytes, and bilayers. By using polymer self-consistent field theory (SCFT) to model such systems, we develop a computationally efficient means to provide physical insights into these systems, which are intended to guide dendrimer design for delivery applications.We study the conformational properties of weakly basic (annealed) polyelectrolyte dendrimers by developing a SCFT model that explicitly accounts for the acid-base equilibrium reaction of the weakly basic monomers. We specifically focus on the role of local counterion concentration upon the charge and conformations of the annealed polyelectrolyte dendrimers. We compare our results to existing polymer scaling theories and develop a strong stretching theory for the dendrimer molecules.We extend the previous study to model the interactions between weakly basic dendrimers and weakly acidic, hydrophobic drug molecules. We specifically examine the effects of excluded volume, electrostatic, and enthalpic interactions on the binding efficacies between dendrimers and drugs under a variety of dendrimer generations, solution pOH conditions, drug sizes, and Bjerrum length values.We study the role of neutral dendrimer grafts on the conformations and drug binding efficacies of dendrimers. We then elucidate how the observed conformational changes affect the charge of the dendrimers. Furthermore, we examine how the presence of grafts affects the steric, electrostatic, and hydrophobic interactions between the drugs and dendrimers under a variety of solution conditions. We compare our results with the binding efficacies observed for non-grafted dendrimers to delineate the conditions under which the grafted dendrimers are better suited as drug hosts.We include semi-flexible, anionic linear polyelectrolyte (LPE) molecules in our grafted dendrimer SCFT framework to model the interactions between dendrimers and negatively charged genetic materials. Specifically, we examine how neutral dendrimer grafts, LPE stiffness, and solution pOH affect the interactions between dendrimers and LPEs. We then use our SCFT potential fields as input into Monte Carlo simulations in order to determine the dendrimer-LPE potentials of mean force and the resulting loop and tail statistics of the dendrimer-adsorbed LPE chains.We incorporate a negatively charged bilayer into our grafted dendrimer SCFT framework to model dendrimer interactions with a cellular membrane. We specifically examine the role of dendrimer grafting length, solution pH, and membrane tension on such interactions. By comparing our results with SCFT calculations of fixed dendrimer conformations and hard sphere nanoparticles in the presence of membranes, we delineate the role of dendrimer flexibility and porosity on the interactions between dendrimers and anionic bilayers. / text

Hydrogels are three-dimension networks of water-soluble polymer chains and have attracted interest in biomedical engineering, targeted drug delivery, tissue engineering, and regenerative medicine due to their ability to retain water coupled with their highly tunable physicochemical and biological properties. In the specific context of wound care, hydrogels can both maintain high wound hydration as well as absorb and manage wound exudate, both of which are major challenges in wound care. Hydrogel wound dressings can simultaneously deliver medication directly to the wound to suppress or treat infections, including antibiotic-resistant strains such as Methicillin-resistant S. aureus (MRSA). This thesis develops two wound care products that can address challenges in the selection and delivery of drugs to treat antibiotic-resistant strain infections: (1) in situ-gelling poly(oligoethylene glycol methacrylate) (POEGMA) hydrogel wound dressings containing self-assembled nanoparticles encapsulated with fusidic acid; and (2) an in situ calcium-crosslinked alginate scaffold produced using pressurized gas expanded liquids (PGX) technology impregnated with fusidic acid or tigecycline using supercritical adsorptive precipitation (sc-AP). The POEGMA hydrogel wound dressings helped supress MRSA infection and prevent systemic infection during the course of treatment, facilitating a 1-2 fold decrease in bacterial load in the wound bed. The sc-AP technology was shown to be compatible with loading clinically-relevant doses of both antimicrobial compounds, while the resulting wound dressings were effective in treating MRSA wound infections. In case of tigecycline loaded alginate scaffolds, the infection was completely cleared. In tissue engineering applications, injectable macroporous hydrogels are particularly limited by two factors: (1) their need for invasive administration, typically implantation; and (2) their generally weak mechanics. In the first case, reports of injectable hydrogels often involve toxic compounds or by-products that result in loss of cell viability. This thesis addresses this challenge by design and development of a POEGMA-based macroporous hydrogel scaffold based on a novel, non-cytotoxic pore forming emulsion based on perfluorocarbons. Use of the pore-forming emulsion significantly improved cell viability in vitro 14 days after injection and was well tolerated in vivo with minimal to no inflammatory response. In the second case, an interpenetrating “hard-soft” nanofibrous hydrogel network was fabricated by co-electrospinning POEGMA with poly(caprolactone) (PCL). The PCL phase significantly enhanced the mechanical properties of the electrospun POEGMA hydrogel scaffold making handling and manipulating the scaffolds possible, while the presence of the POEGMA phase significantly improved the biological properties of PCL scaffolds in terms of supporting significantly enhanced cell proliferation and delayed bacterial adhesion. Collectively, the advances made in this work address key challenges in the application of hydrogels in tissue engineering and wound care, with future potential to be applied to solve practical clinical challenges. / Dissertation / Doctor of Philosophy (PhD) / Hydrogels have been studied in various applications like targeted drug delivery, tissue engineering, regenerative medicine, and medical devices due to their tunable nature and their capacity to retain water. In many of these applications the pore size and porosity are the key to the performance of a hydrogel in a given application. In particular, the rate at which nutrients or wastes can move through a hydrogel, the stiffness of a hydrogel, and the interactions of a hydrogel with cells are all strongly dependent on the porosity of a hydrogel. Therefore, many techniques have been developed to produce hydrogels with well-defined pore sizes, in particular “macroporous” hydrogels that have larger pores at or above the size of a cell. However, the typical techniques used to make such hydrogels often require additives or manufacturing steps that make them challenging to implement in different applications. This thesis addresses challenges in the fabrication of controllable porosity of hydrogels for applications in wound care (including the treatment of antibiotic-resistant infected wounds) and regenerative medicine, in the latter case enabling minimally invasive injection of a macroporous hydrogel as well as enhancing its mechanics to better mimic native tissues. Each of these solutions aims to bring effective novel treatments to patients, offering alternative therapies for existing challenges in healthcare.

An ideal drug delivery system should contain an appropriate therapeutic agent and biocompatible carrier. In this study, we investigated the ability of the all-complementary self-assembling peptide AC8 in stabilizing the anticancer compound and determined the in-vitro therapeutic efficacy of the peptide-mediated anticancer drug delivery. The all-complementary peptide AC8 was designed based on the amino acid pairing principle (AAP), which contains hydrogen bonding, electrostatic, and hydrophobic interaction amino acid pairs. AAP interactions make the peptide capable of self-assembling into β-sheet structure in solution in a concentration dependent manner. Peptide solution concentration is a key parameter in controlling the nanoscale assembling of the peptide. The critical assembly concentration (CAC) of the peptide was found ~ 0.01 mg/ml by several techniques. The all-complementary peptide AC8 was found to be able to stabilize neutral state of hydrophobic anticancer compound ellipticine in aqueous solution. The formation of peptide-ellipticine complex was monitored by fluorescence spectroscopy at different mass ratios of peptide-to-ellipticine. The anticancer activity of the complexes with neutral state of ellipticine was found to show great anticancer activity against two cancer cells lines, A-549 and MCF-7. This peptide-mediated anticancer delivery system showed the induction of apoptosis on cancer cells in vitro by flow Cytometry.

An ideal drug delivery system should contain an appropriate therapeutic agent and biocompatible carrier. In this study, we investigated the ability of the all-complementary self-assembling peptide AC8 in stabilizing the anticancer compound and determined the in-vitro therapeutic efficacy of the peptide-mediated anticancer drug delivery. The all-complementary peptide AC8 was designed based on the amino acid pairing principle (AAP), which contains hydrogen bonding, electrostatic, and hydrophobic interaction amino acid pairs. AAP interactions make the peptide capable of self-assembling into β-sheet structure in solution in a concentration dependent manner. Peptide solution concentration is a key parameter in controlling the nanoscale assembling of the peptide. The critical assembly concentration (CAC) of the peptide was found ~ 0.01 mg/ml by several techniques. The all-complementary peptide AC8 was found to be able to stabilize neutral state of hydrophobic anticancer compound ellipticine in aqueous solution. The formation of peptide-ellipticine complex was monitored by fluorescence spectroscopy at different mass ratios of peptide-to-ellipticine. The anticancer activity of the complexes with neutral state of ellipticine was found to show great anticancer activity against two cancer cells lines, A-549 and MCF-7. This peptide-mediated anticancer delivery system showed the induction of apoptosis on cancer cells in vitro by flow Cytometry.

Le traitement des infections intracellulaires est compliqué par la capacité des bactéries à «se cacher» à l’intérieur des cellules de l’hôte, en particulier celles du système immunitaire, entravant ainsi l’action de nombreux agents antimicrobiens. La diffusion croissante de souches résistantes est très inquiétante. Dans ce cadre, les nanoparticules (NPs) constituent une stratégie prometteuse pour administrer de manière optimisée des agents antimicrobiens.Ce travail de thèse, réalisé dans le cadre du projet européen ITN Cyclon Hit, visait à développer et caractériser des NPs biodégradables et biocompatibles chargées en antibiotiques, composés d’acide polylactique (PLA), d’acide poly (lactique-co-glycolique) (PLGA) et de polycaprolactone (PCL) ou de cyclodextrines polymérisées (pCD).Les deux premiers chapitres sont consacrés aux verrous technologiques liés à l'encapsulation de certains médicaments puissants dans les NPs polymériques. Tout d'abord, ces vecteurs ont été utilisés pour la délivrance simultanée d'une combinaison de molécules actives récemment découverte, l'éthionamide (ETH) et son Booster, pour le traitement de la tuberculose. Deuxièmement, ils ont été employés pour relever les défis liés à l'incorporation d'une quinolone de première génération, l'acide pipémidique (PIP), dans le but d'optimiser sa distribution intracellulaire dans des infections telles que la salmonellose.La co-incorporation efficace de l'ETH et du booster a dû surmonter de nombreuses difficultés liées à des problèmes de solubilité, de cristallisation et de biodisponibilité. Nos NPs en PLA et en pCD ont montré leur capacité de co-encapsuler efficacement les deux molécules et tout particulièrement celles en pCD. Elles incorporent les médicaments à la fois dans les cavités des CD et dans des microdomaines hydrophobes. Les NPs en pCD, non toxiques après administration pulmonaire répétée de fortes doses, ont été administrés in vivo par voie endotrachéale directement au site d'infection. Elles ont permis une diminution de 3-log de la charge bactérienne pulmonaire des animaux infectés après seulement 6 administrations. De même, l'incorporation de PIP a été confrontée à des défis liés à la cristallisation de PIP et à sa libération incontrôlée. Malheureusement, le PIP présentait une faible affinité pour tous les matériaux polymériques étudiés et son encapsulation physique était infructueuse. Ainsi, une approche alternative a été développée en couplant le PIP au PCL via une réaction sans catalyseur initiée par le médicament. Le conjugué PCL-PIP se auto-assemble en forme de NPs avec une charge en PIP de 27%. Cependant, le PCL-PIP n'a pas pu être dégradé in vitro, mais l’approche de synthèse de conjugués est séduisante pour obtenir de particules stables et avec un contenu important en PIP.La compréhension approfondie de la structure et de la composition du noyau et de la couronne des nanostructures contenant une ou deux molécules actives est cruciale pour leur optimisation. Les deux derniers chapitres sont donc consacrés à l'application innovante de l'AFM-IR, une méthode nanospectroscopique originale combinant la microscopie à force atomique (AFM) avec la spectroscopie infrarouge (IR), à l'analyse chimique des NPs en PLGA ou à leur détection sans marquage après internalisation dans les cellules.L’AFM-IR est capable de fournir une caractérisation chimique à l'échelle nanométrique (résolution ~10 nm). Une avancée majeure du travail est l'application du mode tapping permettant l'investigation individuelle de chaque NP. Le signal IR spécifique des composants des NPs a été utilisé pour appréhender la composition chimique de leur cœur et couronne ainsi que pour localiser précisément le médicament. De plus, l'AFM-IR en mode contact a permis pour la première fois la localisation sans marquage et l'identification chimique des NP à l'intérieur des cellules. Ce travail ouvre la voie à d'innombrables applications de cette technique dans le domaine de la nanomedecine. / The treatment of intracellular infections is very challenging given the ability of bacteria to “hide” inside the cells of the host, especially the ones of the immune system, thus hampering the action of many antimicrobial agents. The battle against these bacteria has been further exacerbated by the increasing diffusion of antimicrobial resistant strains. In this frame, nanoparticles (NPs) are a very promising strategy to overcome the limitations of free antimicrobial agents by administering them in an optimized manner.This PhD work, performed as part of the European Project ITN Cyclon Hit, aimed at the development and advanced characterisation of antibiotic-loaded biodegradable and biocompatible NPs made of poly (lactic acid) (PLA), poly (lactic-co-glycolic) (PLGA) and polycaprolactone (PCL) or of polymerised cyclodextrins (pCDs).The first two chapters are dedicated to the encapsulation of powerful but challenging drugs in polymeric NPs. Firstly, these carriers were employed for the simultaneous delivery of a potent drug combination recently discovered, ethionamide (ETH) and its booster, for tuberculosis therapy. Secondly, they were used to address the challenges related to the incorporation of a first-generation quinolone, pipemidic acid (PIP), with the aim of optimising its intracellular delivery in infections such as salmonellosis.The efficient co-incorporation of ETH and booster had to overcome several technological barriers. These drugs presented solubility, crystallisation and bioavailability-related problems which were overcome thanks to the developed NPs. Our engineered PLA and pCD NPs were both able to efficiently co-encapsulate the two molecules. Among the in depth-characterised formulations, pCDs NPs displayed the best physico-chemical properties and were shown to host the drugs both in the CD cavities and in confined spaces inside NPs crosslinked polymer. The pCD NPs were administered in vivo by endotracheal route directly to the infection site. Empty NPs were shown non-toxic after repeated pulmonary administration of high doses. Moreover, loaded pCD NPs led to a 3-log decrease in the pulmonary bacterial load of infected animals after only 6 administrations. Similarly, the incorporation of PIP faced challenges mainly related to PIP crystallization and burst release. Unfortunately, PIP displayed poor affinity for all the studied polymeric materials and its physical encapsulation was unsuccessful. Thus, an alternative approach was developed by coupling PIP to PCL by using an original catalyst-free drug-initiated reaction. The PCL-PIP conjugate self-assembled in NPs with up to 27 wt% PIP which were thoroughly characterised. However, the conjugate couldn’t be enzymatically degraded. With the design of novel PCL-PIP conjugates, this self-assembly approach could represent a promising strategy.The deep understanding of the structure and composition of complex core-corona nanocarriers containing one or two active molecules is crucial for their optimisation. The last two chapters are devoted to the innovative application of AFM-IR, an original nanospectroscopic method combining atomic force microscopy (AFM) with infrared (IR) spectroscopy, to the chemical analysis of PLGA NPs or to their label-free detection after cell internalisation.AFM-IR is able to provide chemical characterisation at the nanometer scale (resolution ~10nm). One main breakthrough here is the application of the recently developed tapping mode allowing the investigation of single polymeric NPs. The specific IR signal of NPs constituents was used to unravel the chemical composition of their core and corona as well as to precisely locate the drug. Moreover, the AFM-IR in contact mode enabled for the first time the label-free localisation and unambiguous chemical identification of NPs inside cells using the polymer IR specific response as a fingerprint. This work paves the way for countless application of this technique in the field of drug delivery.

Polyelectrolyte multilayer capsules fabricated by layer-by-layer (LbL) self-assembly technique consistsing of core-shell structure have emerged as potential drug delivery systems along with their applications in micro-reactors, cosmetics, vaccines and antimicrobial coatings. Various ligands and stimuli responsive entities can be incorporated into the core and shell of the capsules for targeted delivery and/or controlled release applications. Though multilayer capsules have been studied extensively as delivery systems, their utility for encapsulation of hydrophobic drugs and multiple drugs have not been explored in detail so far. Application of traditional polyelectrolyte capsules has several limitations, which renders them inapplicable for encapsulation of multiple drugs, hydrophobic drugs and also for releasing drugs on demand without addition of the external photothermal agents such as metal nanoparticles into the shells of the capsules. Thus, in this thesis, an attempt has been made to develop novel multifunctional multilayered capsules to overcome the above mentioned limitations. We have formulated two novel methods to functionalize the core with cyclodextrin molecules and the shell of the capsules with two-dimensional material, graphene oxide (GO). The properties such as high surface area along with π bonds, broad NIR-absorption, superior photothermal conversion and antimicrobial activity of graphene oxide has been explored and it has been demonstrated that 2-D graphene oxide is unique compared to the regular polyelectrolytes. By functionalizing the shell of capsules with GO as one of the layer material, a simple and efficient way for encapsulating multiple drugs into core and shell of the capsules is achieved by utilizing the large surface area and amphiphilic nature of GO. Based on the unique optical absorption and photothermal conversion properties of GO, we have demonstrated a facile route for near-infrared (NIR)-laser triggered release with low laser power. In the second part, functionalization of the hollow core of the capsules has been functionalized using cylodextrin (CD)-incorporated CaCO3 porous sacrificial templates, where both CD-CaCO3 and CD-modified capsules are used as high efficient carriers for hydrophobic drugs. In the third part, synergistic antimicrobial therapy was achieved using composite graphene oxide/polymer LbL films by combining the intrinsic antimicrobial activity and photothermal conversion ability of graphene oxide and the results depicted superior antimicrobial activity towards E. coli. These composite films also can be used as efficient antimicrobial coatings on biomedical devices or implants. The thesis has been divided into five chapters based on the individual works. In Chapter 1, a brief review on the history of LbL self-assembly, mechanism of self-assembly along with factors affecting the process have been discussed. Followed by a brief discussion about the fabrication of multilayered hollow capsules (core-shell structure), their applications in drug delivery and fabrication of multifunctional multilayered capsules through core and shell have been discussed. Finally, recent developments in LbL self-assembly and multilayered hollow capsules using carbon based materials (fullerenes, carbon nanotubes and graphene oxide) and their biomedical applications have been presented. Chapter 2 deals with the study on fabricating multifunctional multilayered capsules for facile encapsulation of multiple drugs into the capsules, which is achieved by functionalizing the capsules with graphene oxide (GO) as one of the layer materials. The GO composite capsules exhibited unique permeability properties compared to traditional multilayered capsules made of two polyelectrolytes. Multiple drugs could be simultaneously encapsulated in the capsules in a simple and effective manner. These capsules were found to exhibit a “core-shell” loading property for encapsulation of dual drugs into the core and shell of the capsules respectively. In addition, the graphene oxide composite capsules showed excellent biocompatibility towards MCF-7 cells. This study is the first one that demonstrates the potential of hybrid polyelectrolyte capsules without the use of micelles or polymer-drug conjugates for multi-drug encapsulation. Chapter 3 deals with the development of a facile route for near-infrared (NIR)-light triggered release of encapsulated drugs from the multilayered capsules via incorporation of graphene oxide (GO) into layer-by-layer (LbL) assembled capsules without addition of any external additives such as metal nanoparticles (NPs) or carbon nanotubes (CNTs) into the shells of the capsules. Till now, there is no report on light-responsive drug delivery system by utilizing the NIR-optical absorption properties of GO. Here, graphene oxide (GO) plays a dual role, serving as a structural component of LbL capsules as well as strong NIR-light absorbing agent, which efficiently converts absorbed light into heat. Upon NIR-laser irradiation, the microcapsules were opened in “point-wise fashion” due to local heating caused by laser irradiation. The rupturing mechanism of the capsules has been clearly demonstrated using confocal fluorescence microscopy and high resolution transmission electron microscopy. The light-triggering ability of these capsules has been applied successfully to release the encapsulated anticancer drug, doxorubicin. Chapter 4 deals with simple and versatile simple routes for encapsulation of model hydrophobic drug. Encapsulation of hydrophobic drugs in pharmaceutical industries is always a big challenge due to limited number of available drug carrier systems and poor aqueous solubility of hydrophobic drugs. Here, by combining the special properties of cyclodextrins (CDs) with biodegradable inorganic calcium carbonate microparticles, the hybrid CD-CaCO3 mesoporous microparticles have been prepared for the first time. These CD-CaCO3 microparticles were utilized as sacrificial templates to prepare CDs-modified LbL capsules. We have demonstrated that both the hybrid CD-CaCO3 microparticles and CDs-modified capsules are potential carriers for encapsulation of model hydrophobic drugs (self-fluorescent coumarine and nile red dyes) with high loading efficiency using supramolecular host-guest interaction between entrapped CDs and hydrophobic dye molecules. Compared with other inorganic drug carrier systems (mesoporous silica), CaCO3 porous particles have better biocompatibility, biodegradability and cost-effective and without use of any organic solvents. Both these hybrid CD-CaCO3 microparticles and CDs-modified capsules can be good candidates for encapsulation of hydrophobic drugs without involving extreme chemical conditions for fabrication. Chapter 5 deals with development of facile synergistic method for killing pathogenic bacteria by combining the intrinsic antimicrobial activity of graphene oxide (GO) and unique photothermal conversion property of GO into a single material. We fabricated composite LbL films of graphene oxide (GO) and poly(allylamine hydrochloride) (PAH) films. Antimicrobial activity of these GO composite films has been studied using Escherichia coli (E. coli) cells by varying number of deposited layers on glass slides (20 to 80 layers) and results suggest that by increasing the number of deposited layers, antimicrobial activity is also increased gradually. Based on the unique optical properties of GO, photothermal therapy have been carried out for killing of E. coli using GO composite films by varying number of deposited layers (20 to 80 layers) by irradiation of NIR-pulse laser at 1064 nm wavelength (Nd:YAG, 10 ns pulse, 10 Hz). The photothermal results revealed the enhanced antimicrobial activity compared to GO composite films alone without NIR-laser irradiation. The synergistic photothermal killing ability along with intrinsic antimicrobial activity of GO films results in much faster killing compared to films alone.

Η Πακλιταξέλη (PTX) αποτελεί ένα ευρέως διαδεδομένο αντινεοπλασματικό φάρμακο και ενδείκνυται σε μεταστατικό καρκίνο του μαστού, καρκίνο ωοθηκών, μη μικροκυτταρικό καρκίνο του πνεύμονα και σε σάρκωμα Kaposi ασθενών με AIDS. Παρ’ όλα αυτά, η σημαντική τοξικότητα που εμφανίζει (μυελοκαταστολή, νευροτοξικότητα, αντιδράσεις υπερευαισθησίας), υπογραμμίζει την αναγκαιότητα για μορφοποίησή της σε Συστήματα Ελεγχόμενης Χορήγησης Φαρμάκων (DDS), με σκοπό τη μείωση των ανεπιθύμητων ενεργειών και την αύξηση της βιοδιαθεσιμότητας του φαρμάκου. Τα πολυμερικά μικκύλια έχουν μελετεθεί εκτενώς τα τελευταία χρόνια ως Συστήματα Ελεγχόμενης Χορήγησης Φαρμάκων. Η ενσωμάτωση υπερπαραμαγνητικών νανοκρυσταλλιτών οξειδίου του σιδήρου (SPIONs) στον πυρήνα των PTX-μικκυλίων, παρέχει τη δυνατότητα μαγνητικής στόχευσης του φαρμάκου στην επιθυμητή περιοχή δράσης, καθώς και τη θεραπεία του καρκίνου μέσω επαγωγής μαγνητικής υπερθερμίας, με την εφαρμογή εναλλασσόμενου μαγνητικού πεδίου. Επιπλεόν, η χρήση των SPIONs ως σκιαγραφικά μέσα (Τ2-contrast enhancement) στη μαγνητική τομογραφία πυρηνικού συντονισμού (MRI), εξασφαλίζει το πλεονέκτημα ταυτόχρονης διάγνωσης και θεραπείας (Theranostics), αποκαλύπτοντας την πολυλειτουργικότητα των συστημάτων αυτών. Οι συγκεκριμένοι νανοφορείς, έχοντας μικρό μέγεθος (100-200nm), θεωρούνται κατάλληλοι για να αποφύγουν την οψωνινοποίηση απο τις λιποπρωτεϊνες του αίματος, την επίθεση απο τα φαγοκύτταρα του Δικτυοενδοθηλιακού συστήματος (RES) καθώς και την ταχεία νεφρική κάθαρση, με αποτέλεσμα την παρατεταμένη κυκλοφορία τους στο αίμα (stealth systems) και την εκλεκτική πρόσληψη τους απο τους συμπαγείς καρκινικούς όγκους, μέσω του φαινομένου της ενισχυμένης διαπερατότητας και κατακράτησης (EPR effect). Οι ιδιότητες αυτές, καθιστούν τα συγκεκριμένα συστήματα πολύτιμα εργαλεία στον τομέα της νανοϊατρικής. Η παρούσα μεταπτυχιακή διατριβή πραγματεύεται τη σύνθεση υδρόφοβων SPIONs μέσω της τεχνικής της θερμικής αποικοδόμησης. Μελετήθηκαν οι συνθετικές παράμετροι (πρόδρομη ένωση, ποσότητα ελαϊκού οξέος, θερμοκρασία και διάρκεια αντίδρασης, ρυθμός αύξησης της θερμοκρασίας κ.α) που επηρεάζουν το μέγεθος, το σχήμα και τη διασπορά του μεγέθους των σχηματιζομένων νανοκρυσταλλιτών (5-13nm, σ: 10-20%), καθώς διαδραματίζουν σημαντικό ρόλο στη μαγνητική συμπεριφορά των υβριδικών νανονοφορέων. Στη συνέχεια, πραγματοποιήθηκε σύνθεση υβριδικών νανοφορέων με εγκλωβισμό των SPIONs σε πολυμερικά μικκύλια. Η παρασκευή των υπερπαραμαγνητικών μικκυλίων επιτελέστηκε με την τεχνικη solvent diffusion and evaporation (nanoprecipitation), με χρήση του αμφίφιλου συμπολυμερούς πολυ(γαλακτικό οξύ)-πολυ(αιθυλενογλυκόλη) (PLA-PEG). Στον υδρόφοβο πυρήνα των μικκυλίων (PLA) δεσμεύονται υδρόφοβες ενώσεις (PTX, SPIONs), ενώ το υδρόφιλο κέλυφος (PEG) προσδίδει κολλοειδή σταθερότητα σε υδατικά μέσα (δομή πυρήνα-κελύφους). Διερευνήθηκαν διάφορες συνθετικές παράμετροι (μοριακό βάρος συμπολυμερούς, ποσότητα SPIONs, ρυθμός προσθήκης οργανικής φάσης κ.α) και προσδιορίστηκαν οι βέλτιστες συνθήκες για την παρασκευή υπερπαραμαγνητικών μικκυλίων μεγέθους <200nm, με αξιοσημείωτη κολλοειδή σταθερότητα (μέχρι και έξι μήνες), σε συνθήκες παρόμοιες με αυτές του ανθρώπινου πλάσματος (pH: 7.4, ιοντική ισχύς: 0.15Μ). Στο επόμενο στάδιο της παρούσας εργασίας, μελετήθηκαν οι παράγοντες που επηρεάζουν τη φόρτωση-ενκαψυλίωση της PTX και των SPIONs στα πολυμερικά μικκύλια (ποσότητα PTX, ποσότητα και μέγεθος SPIONs, μοριακό βάρος PLA-PEG, ρυθμός προσθήκης οργανικής φάσης κ.α), σε φυσιολογικές συνθήκες (pH:7.4, ιοντική ισχύς: 0.15Μ). Αναπτύχθηκε πρωτόκολλο μέσω του οποίου έγινε κατορθωτός ο διαχωρισμός των μαγνητικών νανοφορέων απο τους μη μαγνητικούς, καθώς και ο υπολογισμός της φόρτωσης-ενκαψυλίωσης PTX και SPIONs ξεχωριστά, τόσο στους μαγνητικούς και μη μαγνητικούς νανοφορείς, όσο και στο μέιγμα αυτών. Οι συγκεκριμένοι νανοφορείς χαρακτηρίζονται απο εξαιρετικά υψηλή απόδοση ενκαψυλίωσης φαρμάκου (93 %wt.) και φόρτωση φαρμάκου που ανέρχεται στο 4.8 %wt. Oι αμιγώς μαγνητικοί νανοφορείς επιδεικνύουν υψηλή απόδοση ενκαψυλίωσης νανοκρυσταλλιτών (70 %wt.), ενώ η φόρτωση σε φάρμακο και SPIONs ανέρχεται σε 5.2 και 20 %wt. αντίστοιχα. Σε αμφότερες τις περιπτώσεις οι νανοφορείς, μεγέθους (υδροδυναμική διάμετρος) 170nm, χαρακτηρίζονται απο ικανοποιητική μαγνητική συμπεριφορά. Εξετάστηκε η επίδραση του μεγέθους των νανοκρυσταλλιτών στη μαγνητική συμπεριφορά των νανοφορέων. Οι αμιγώς μαγνητικοί νανοφορείς με μεγαλύτερο μέγεθος SPIONs παρουσιάζουν καλύτερη μαγνητική συμπεριφορά. Τέλος, πραγματοποιήθηκαν μελέτες αποδέσμευσης του φαρμάκου σε PBS (0.14Μ, pH:7.4) στους 37oC και διερευνήθηκε η επίδραση της εφαρμογής εναλλασσόμενου μαγνητικού πεδίου στην αποδέσμευση της PTX απο τους μαγνητικούς νανοφορείς (Triggered Drug Release). Σε κάθε περίπτωση, παρατηρήθηκε ελεγχόμενη αποδέσμευση του φαρμάκου για 24 ώρες, σε συνθήκες που προσομοιάζουν με αυτές του πλάσματος. Ο φυσικοχημικός χαρακτηρισμός των νανοφορέων πραγματοποιήθηκε με HPLC, DLS, TGA, TEM και μαγνητοφόρηση. / Paclitaxel (PTX) is one of the most successful anticancer drugs against a broad range of solid tumors, such as metastatic breast cancer, ovarian cancer, non-small-cell lung cancer and AIDS-related Kaposi sarcoma. However, the serious systematic side effects of PTX (myelosuppression, neurotoxicity, hypersensitivity) underline the need for formulation of PTX in Drug Delivery Systems (DDS), in order to reduce the side effects and increase the bioavailability of the drug. Among DDS, polymeric micelles have drawn much attention due to their great flexibility in tuning drug solubility, micelle size, targeted drug delivery and stability. Incorporation of Superparamagnetic Iron Oxide Nanocrystals (SPIONs) inside the core of drug-loaded polymeric micelles, imparts to the final Drug Delivery System the prospect of physical (magnetic) targeting, intrinsic therapeutic function (hyperthermia-based cancer therapy under alternating external magnetic field), T2-based contrast enhancement in magnetic resonance imaging (MRI) and remotely triggered drug release. These core-shell polymeric micelles having small size (100-200nm), are considered appropriate for avoiding both opsonization, macrophages attack by ReticuloEndothelial System (RES) and rapid renal clearance, thus allowing micelles to be taken up preferably by solid tumors through Enhanced Permeability and Retention (EPR) effect. Therefore, such nanoassemblies encode high potential in nanomedicine, due to their dual nature (Therapeutic+Diagnostic = Theranostics). In particular, we have studied the synthesis of organophilic SPIONs through thermal decomposition. The synthetic parameters (precursor, precursor:oleic acid ratio, reaction temperature and duration, heat rate, etc.) affecting the size, shape and size distribution of the nanocrystals have also been examined thoroughly, since they play a key-role concerning the magnetic behavior of the final hybrid. Nanosized SPIONs with narrow size distribution were synthesized (5-13nm, σ: 10-20%). The preparation of poly(lactic acid)-block-poly(ethyleneglycol) (PLA-PEG) micelles encapsulating hydrophobic SPIONs, by varying the molecular weight of the polymers, the amount of SPIONs and the addition rate during micelle assembly, has also been investigated. The core-shell superparamagnetic micelles were prepared through solvent diffusion and evaporation technique (nanoprecipitation). PTX and SPIONs are being incorporated into the micelle’s hydrophobic core (PLA) through hydrophobic interactions, whereas the hydrophilic shell (PEG) stabilizes the micelles in aqueous dispersions, optimizing their colloidal stability and providing prolonged circulating time. The optimum parameters were determined, conferring to the micelles (Hydrodynamic Diameter < 200nm) high colloidal stability (up to six months) at biorelevant conditions (pH:7.4, ionic strenght: 0.15M). The next phase of the present master thesis focused on studying the factors (amount of PTX and SPIONs, molecular weight of PLA-PEG, addition rate, etc.) affecting the Loading of PTX and SPIONs into the polymeric micelles and how they can be fine-tuned towards high drug loading, while retaining their size at a scale where long circulation would not be precluded. Through protocol establishment, we have managed to separate the magnetic and non magnetic micelles, and to determine individually the loading of PTX and SPIONs for magnetic, non magnetic micelles, as well as for the mixture of them. The micelles’ mixture exhibits very high Drug Encapsulation Efficiency (93 %wt.) and 4.8 %wt. Drug Loading (D.L). Magnetic nanocarriers display high Magnetic Encapsulation Efficiency (70 %wt.), with D.L and Magnetic Loading of 5.2 and 20 %wt. respectively, In both cases, micelles demonstrate adequate magnetic behavior and small sizes (hydrodynamic diameter: 170nm), under conditions which simulate with human plasma (pH:7.4, ionic strenght: 0.15M). The effect of SPIONs’ size on the magnetic behavior of hybrid colloids, was also examined. Magnetic nanocarriers encapsulating SPIONs of greater size exhibit better magnetic behavior. Finally, we have conducted Drug release studies in PBS (0.14M, pH:7.4) at 37oC. The effect of SPIONs presence on the release profile of PTX, including triggered drug-release by application of AC magnetic field, has also been investigated. PTX-magnetic micelles exhibit Controlled Drug release for 24 hours. Several techniques have been used for the characterization of such nanoassemblies, like: HPLC, DLS, TGA, TEM, XRD, Magnetophoresis and Triggered Drug release by application of AC magnetic field.